These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30444968)

  • 1. Managing antiretroviral therapy in the elderly HIV patient.
    Guaraldi G; Pintassilgo I; Milic J; Mussini C
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1171-1181. PubMed ID: 30444968
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing issues in elderly individuals living with HIV.
    Marzolini C; Livio F
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):643-659. PubMed ID: 31155978
    [No Abstract]   [Full Text] [Related]  

  • 3. The challenge of HIV treatment in an era of polypharmacy.
    Back D; Marzolini C
    J Int AIDS Soc; 2020 Feb; 23(2):e25449. PubMed ID: 32011104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults.
    Novaes PH; da Cruz DT; Lucchetti ALG; Leite ICG; Lucchetti G
    Int J Clin Pharm; 2017 Aug; 39(4):818-825. PubMed ID: 28455830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on drug-drug interactions in older adults living with human immunodeficiency virus (HIV).
    Linfield RY; Nguyen NN; Laprade OH; Holodniy M; Chary A
    Expert Rev Clin Pharmacol; 2024 Jul; 17(7):589-614. PubMed ID: 38753455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
    Kong AM; Pozen A; Anastos K; Kelvin EA; Nash D
    AIDS Patient Care STDS; 2019 Mar; 33(3):93-103. PubMed ID: 30844304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing Polypharmacy in Older Adults Living With HIV.
    Harmon JL; McGee KS
    J Assoc Nurses AIDS Care; 2019; 30(1):73-79. PubMed ID: 30586084
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of drug-drug interactions in older HIV-infected patients.
    Chary A; Nguyen NN; Maiton K; Holodniy M
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1329-1352. PubMed ID: 28922979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of polypharmacy in people living with HIV.
    Marin S; Quiñones C; Codina-Jiménez C; Valls E; Terricabras E; Estrada L; Cardona G; Andreu À
    AIDS Rev; 2023; 25(1):27-40. PubMed ID: 36952662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy in the HIV-infected older adult population.
    Gleason LJ; Luque AE; Shah K
    Clin Interv Aging; 2013; 8():749-63. PubMed ID: 23818773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.
    Nachega JB; Hsu AJ; Uthman OA; Spinewine A; Pham PA
    AIDS; 2012 Jul; 26 Suppl 1():S39-53. PubMed ID: 22781176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases.
    Cantudo-Cuenca MD; Gutiérrez-Pizarraya A; García-Lloret P; Gabella-Bazarot E; Morillo-Verdugo R
    Eur J Hosp Pharm; 2024 Jun; 31(4):339-343. PubMed ID: 36585218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of multimorbidity and polypharmacy in older people living with HIV.
    Yang C; Teh YE; Chua NGS; Lee KLS; Ng RQM
    Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():49-59. PubMed ID: 37940135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
    Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;
    J Antimicrob Chemother; 2017 Oct; 72(10):2879-2886. PubMed ID: 28605493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
    Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
    Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Polypharmacy and Frailty Among Thai Older Persons Living with HIV.
    Sangarlangkarn A; Apornpong T; Woodard J; Jordan A; Avihingsanon A
    AIDS Res Hum Retroviruses; 2022 Jul; 38(7):538-543. PubMed ID: 35323049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric Conditions Associated with Nonadherence to Antiretroviral Therapy Among Older People with HIV: The Importance of Frailty.
    Olivieri-Mui B; Wilson I; Shi S; Montano M; McCarthy EP; Oh G; Kim DH
    AIDS Patient Care STDS; 2022 Jun; 36(6):226-235. PubMed ID: 35687816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of polypharmacy on antiretroviral prescription in people living with HIV.
    Guaraldi G; Menozzi M; Zona S; Calcagno A; Silva AR; Santoro A; Malagoli A; Dolci G; Mussi C; Mussini C; Cesari M; Khoo SH
    J Antimicrob Chemother; 2017 Feb; 72(2):511-514. PubMed ID: 27834193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV.
    Calcagno A; Trunfio M; D'Avolio A; Di Perri G; Bonora S
    Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):665-676. PubMed ID: 33913394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging clinical issues related to management of multiorgan comorbidities and polypharmacy.
    Vigouroux C; Bastard JP; Capeau J
    Curr Opin HIV AIDS; 2014 Jul; 9(4):371-8. PubMed ID: 24824887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.